Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics Revenue

Axsome Therapeutics had revenue of $191.20M in the quarter ending March 31, 2026, with 57.42% growth. This brings the company's revenue in the last twelve months to $708.24M, up 63.88% year-over-year. In the year 2025, Axsome Therapeutics had annual revenue of $638.50M with 65.55% growth.

• Revenue (ttm): $708.24M
• Revenue Growth: +63.88%
• P/S Ratio: 16.18
• Revenue / Employee: $580,521
• Employees: 1,220
• Market Cap: 11.80B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	638.50M	252.80M	65.55%
Dec 31, 2024	385.69M	115.09M	42.53%
Dec 31, 2023	270.60M	220.56M	440.80%
Dec 31, 2022	50.04M	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: May 4, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error